TrialThe Journal of urology2023

Nadir Prostate-specific Antigen as an Independent Predictor of Survival Outcomes: A Post Hoc Analysis of the PROSPER Randomized Clinical Trial.

Maha Hussain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.